GlassScriptPhysician profile
Brett R Grebing
NPI 1447252978
$17,544.53
in general payments reported to CMS, 2019-2025
21 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,783 · 2020: $4,469 · 2021: $468 · 2022: $488 · 2023: $541 · 2024: $2,439 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,805 · Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,805.01 |
| Food and Beverage | $1,532.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $11,084.99 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Elite Orthopedics, LLC | $2,710.45 | 2019-2025 | |
| Arthrex, INC. | $2,279.35 | 2019-2024 | |
| Stryker Corporation | $392.77 | 2019-2025 | Mako, Augment Injectable, Gamma |
| Depuy Synthes Sales INC. | $166.62 | 2024-2025 | Na, Monovisc |
| Kci USA, INC. | $142.65 | 2020 | |
| Acera Surgical, INC. | $139.43 | 2023 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $135.83 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Medline Industries LP | $130.37 | 2022 | |
| Linvatec Corporation | $112.84 | 2024 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $34.69 | 2019 | |
| Organogenesis INC. | $29.59 | 2024 | Puraply Am |
| Curonix LLC | $26.69 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Heraeus Medical, LLC. | $24.83 | 2024 | |
| Axogen | $24.54 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $24.49 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.24 | 2025 | Exparel |
| Bioventus LLC | $17.74 | 2019 | |
| Solventum Corporation | $17.67 | 2024 | Prevena |
| Fidia Pharma USA INC. | $13.43 | 2023 | Hymovis |
| Medacta USA, INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Grebing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.